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Successful multidrug-resistant clones are increasing in prevalence globally, which makes the ability to identify these clones ur-
gent. However, adequate, easy-to-perform, and reproducible typing methods are lacking. We investigated whether DiversiLab
(DL), an automated repetitive-sequence-based PCR bacterial typing system (bioMérieux), is suitable for comparing isolates ana-
lyzed at different geographic centers. A total of 39 Escherichia coli and 39 Klebsiella species isolates previously typed by the coor-
dinating center were analyzed. Pulsed-field gel electrophoresis (PFGE) confirmed the presence of one cluster of 6 isolates, three
clusters of 3 isolates, and three clusters of 2 isolates for each set of isolates. DL analysis was performed in 11 centers in six differ-
ent countries using the same protocol. The DL profiles of 425 E. coli and 422 Klebsiella spp. were obtained. The DL system
showed a lower discriminatory power for E. coli than did PFGE. The local DL data showed a low concordance, as indicated by the
adjusted Rand and Wallace coefficients (0.132 to 0.740 and 0.070 to 1.0 [E. coli] and 0.091 to 0.864 and 0.056 to 1.0 [Klebsiella
spp.], respectively). The central analysis showed a significantly improved concordance (0.473 to 1.0 and 0.290 to 1.0 [E. coli] and
0.513 to 0.965 and 0.425 to 1.0 [Klebsiella spp.], respectively). The misclassifications of profiles for individual isolates were
mainly due to inconsistent amplification, which was most likely due to variations in the quality and amounts of the isolated DNA
used for amplification. Despite local variations, the DL system has the potential to indicate the occurrence of clonal outbreaks in
an international setting, provided there is strict adherence to standardized, reproducible DNA isolation methods and analysis
protocols, all supported by a central database for profile comparisons.
The prevalence of successful multidrug-resistant clones, e.g.,Klebsiella pneumoniae ST258 and Escherichia coli ST131, is in-
creasing globally (1–4). The spread of these high-risk clones is
aided by increases in international travel, medical treatment
abroad, and repatriated patients (5, 6). The ability to identify these
epidemic clones is of importance for understanding the epidemi-
ology of these isolates and may alert hospitals to the emergence of
epidemic strains. This requires a reliable typing method capable of
identifying the epidemic clones that can be used at different cen-
ters together with an internationally accessible database for com-
parisons (7). Pulsed-field gel electrophoresis (PFGE) and multilo-
cus sequence typing (MLST) have been used for this purpose. The
main drawback of PFGE, however, is poor reproducibility due to
technical variations and the time-consuming nature of the
method, whereas MLST lacks sufficient discriminatory power.
Multiple-locus variable-number tandem-repeat analysis (MLVA)
and amplified fragment length polymorphism analysis (AFLP) are
also typing methods with databases, but these methods are not
widespread and also have technical limitations (8–10).
The DiversiLab (DL) bacterial typing system (bioMérieux,
Marcy l’Etoile, France), which allows results to be obtained within
a day, may offer an alternative, although it is based on repetitive-
sequence-based PCR (rep-PCR), which also shows poor repro-
ducibility (11, 12). By standardization of the procedures (PCR and
analysis of the amplification products) and the use of a commer-
cial microfluidics system, the DL system has improved reproduc-
ibility and the potential for multicenter comparisons of typing
data, thereby possibly facilitating the identification of interna-
tional clones. The method can be easily introduced into routine
settings and requires less hands-on time than PFGE. The ease of
use is also facilitated by the associated website that allows easy
analysis and visualization of the data. However, comparisons be-
tween different centers have not yet been performed. The aim of
this study was to evaluate the interlaboratory reproducibility of
DL analysis for E. coli and Klebsiella species isolates in an interna-
tional multicenter setting. Eleven centers in six countries typed 39
E. coli and 39 Klebsiella species isolates, which were previously
characterized by PFGE and represent either outbreaks or unique
isolates.
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Isolates and centers. In total, 39 E. coli and 39 Klebsiella species (34 K.
pneumoniae and 5 Klebsiella oxytoca) isolates that had been typed previ-
ously by PFGE were selected from the collections of the Hospital Hygiene
Department of the University Medical Center Utrecht and a study on the
population distribution of -lactamases conferring resistance to broad-
spectrum cephalosporins in human clinical isolates in the Netherlands
(13). The clustering in PFGE was based on a cutoff of 80% and was in
agreement with epidemiological data. Repeated PFGE typing of the two
groups confirmed one cluster of 6 isolates, three clusters of 3 isolates each,
three clusters of 2 isolates, and 18 isolates with unique profiles. The iso-
lates were initially identified by standard microbiology methods and later
confirmed by matrix-assisted laser desorption ionization–time of flight
mass spectrometry (MALDI-TOF MS) (Bruker Daltonics, Germany).
The isolates, from a single plate, were shipped on M40 Transystem
Amies agar gel transport swabs (Copan Italia SpA, Brescia, Italia) to the 11
participating centers in 6 countries, including 5 countries in Europe (Aus-
tria, England, Germany, Spain, and the Netherlands) and Canada.
Typing. All centers used the same protocol. The DNA was isolated
using an UltraClean microbial DNA isolation kit (Mo-Bio Laboratories
Inc., Carlsbad, CA, USA) with two changes for the Klebsiella species iso-
lates, according to the manufacturer’s instructions. Based on previous
experience (8), it was recommended that all centers use a 10-l loop of
bacteria and 900 l of the MD3 solution. A highly sensitive spectropho-
tometer, the NanoDrop, or an equivalent instrument was used to quantify
the DNA. The minimal required concentration was 25 ng/l. The DNA
was required to have an optical density at 260 nm (OD260)/OD280 ratio of
1.7 and an OD260/OD230 ratio of 1.3. Each center performed PCRs
with AmpliTaq (Invitrogen, Breda, the Netherlands) and the kits specified
by the manufacturer for E. coli (kit no. 270613) and Klebsiella spp. (kit no.
270615). The PCR products were analyzed using standard chips (no.
270670). Each center uploaded the chip results to its own bioMérieux
DiversiLab website for local analysis.
Data analysis and statistical methods. The analysis of the profiles was
performed at two levels. First, all profiles were analyzed at the level of the
individual laboratory, and second, all profiles were examined by the staff
at the coordinating center. All centers received the same protocol for
analysis of the data at the first level. The recommendation was that DL
results to be used for comparisons should lack automatic warnings and
have peak intensities of 100 for at least one peak. The analysis was
performed using Pearson’s correlation in the dedicated DL software of the
manufacturer (version 3.4). Isolates with similarities of 95% were con-
sidered different, and isolates with similarities of 98% were considered
indistinguishable. All isolates with similarities of 95% and 98% were
judged manually using the pattern overlay of the analysis tool in the soft-
ware.
The statistical analysis (adjusted Rand’s and Wallace’s coefficients)
was performed using the online tool of the Instituto de Medicina Molec-
ular of the University of Lisbon (http://darwin.phyloviz.net/Comparing
Partitions/index.php). The discriminatory power was estimated by Simp-
son’s index of diversity (14). Ninety-five percent confidence intervals
(95% CIs) for discriminatory indices were calculated according to the
method of Grundmann et al. (15). Nonoverlapping CIs were regarded as
representing statistically significant differences in discriminatory power
(15).
Isolates designated nontypeable, defined as failing to meet the mini-
mal criteria of peak intensities, were included in the statistical analysis as
unique values. All nonprocessed and nonviable isolates and isolates that
could not be amplified, defined as those failing to generate an amplifica-
tion product in the PCR step, were removed from the statistical analyses.
PFGE data were not communicated to the local centers.
The central analysis was performed by the chief investigators (G.M.V.
and A.C.F.). The data were also transferred to a dedicated website created
by bioMérieux with the same DL analysis software as that used by the
individual centers for the analysis of the combined data. The data were
judged manually using the pattern overlay of the analysis tool in the soft-
ware. The statistical analysis was performed as described above for the
local analyses.
RESULTS
The typing data for 425 of 429 E. coli and 422 of 429 Klebsiella
species samples were available for analysis. Three of the E. coli
samples were not processed (1%), and one showed no amplifi-
cation in one of the centers (1%). Similarly, seven of the Kleb-
siella samples (1%) were not processed (1%). The analyses per-
formed by the individual centers were confirmed by the central
laboratory.
The local analyses showed little consensus (Fig. 1A), which was
confirmed by the adjusted Rand and Wallace coefficients (see Ta-
bles S1 and S2 in the supplemental material). Nevertheless, the
local analyses of the E. coli DL data agreed in 96% of the cases for
half of the unique isolates according to PFGE (Fig. 1A, bottom 9
isolates). A similar level of consensus was obtained for the cluster
consisting of isolates 31E and 32E and the cluster consisting of
isolates 14E, 24E, and 25E. However, there was no consensus in
the assignment for the isolates in the other three clusters. The lack
of consensus was confirmed by the adjusted Rand and Wallace
coefficients (see Tables S1 and S2 in the supplemental material),
with mean values of 0.357 and 0.389, respectively. The two statis-
tical analyses showed poor overall values (ranges, 0.132 to 0.740
and 0.070 to 1.0, respectively). An exception for the adjusted Wal-
lace coefficients was the comparison with center 3, which was due
to the fact that this analysis resulted in one big cluster that encom-
passed the smaller clusters identified by other centers.
For E. coli, the DL analyses from the local centers showed less
discriminatory power than did the PFGE analyses. Examples of
this are the DL clusters with isolates 31E and 32E, 18E and 37E,
and 14E, 24E, and 25E (Fig. 1A).
The central analysis of the E. coli DL data also resulted in less
discriminatory power than did the PFGE analysis, which is re-
flected by the lower Simpson index of diversity (see Table S3 in the
supplemental material). The Simpson index of diversity was 0.964
(95% CI, 0.935 to 0.992) for PFGE and ranged from 0.709 (95%
CI, 0.550 to 0.867) to 0.864 (95% CI, 0.767 to 0.961). However, it
showed improved consensus between the data from the different
centers (Fig. 1B; see also Tables S4 and S5 in the supplemental
material) compared to that for the local analyses. This was most
apparent in the cluster consisting of 22E and 39E, the cluster con-
sisting of 18E and 37E, and the cluster consisting of 34E up to and
including 11E in Fig. 1B, which improved significantly in concor-
dance, as is reflected in the adjusted Rand and Wallace coefficients
(see Tables S4 and S5 in the supplemental material). The adjusted
Rand coefficients have a mean value of 0.8 (range, 0.473 to 1.0).
The average was mainly lowered by the results obtained by center
11. The directional adjusted Wallace coefficient also reflected the
improved concordance with a mean value of 0.83, and for 6 of the
11 centers, the mean was 0.9 (range, 0.290 to 1.0).
The Klebsiella spp. were not separated into different species, as
most of them were K. pneumoniae (n  34) or K. oxytoca (n  5),
and these were unique isolates based on PFGE. The assignments of
Klebsiella spp. agreed in 97% of the cases for two-thirds of the
unique isolates according to PFGE (Fig. 2A, last 12 isolates). The
concordance of the isolates belonging to a cluster was larger than
that found for E. coli, although more outliers were present. This is
reflected in the overall higher and more consistent values of the
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adjusted Rand and Wallace coefficients (see Tables S6 and S7 in
the supplemental material), although both statistical analyses
show poor overall values (ranges, 0.091 to 0.864 and 0.056 to 1.0,
respectively). An exception to this finding for the adjusted Wallace
coefficients is center 9, where the analysis identified one big cluster
which encompassed the smaller clusters that the other centers
identified.
In comparison to the PFGE analysis for Klebsiella spp., the DL
analysis did not show a significant difference in the discriminatory
power in the local analyses (Fig. 2A; see also Tables S6 and S7 in the
supplemental material). Examples of this are the isolates 03K and
35K and 37K.
A marked improvement in the degree of concordance between
the centers was obtained by the central analysis, and the discrim-
inatory power remained acceptable (Fig. 2B; see also Table S3 in
the supplemental material). Most notably, the formation of the
cluster containing the isolates 23K, 09K, and 36K, the cluster con-
sisting of 02K and 33K, the cluster consisting of 26K and 31K, the
cluster consisting of 37K and 35K, and the cluster consisting of
21K and 38K improved significantly in concordance. This is re-
flected in the statistical analysis (see Tables S8 and S9 in the sup-
plemental material); the adjusted Rand coefficients have a mean
value of 0.71 (range, 0.513 to 0.965). The values of the adjusted
Wallace coefficient also increased in comparison to that for the
local analyses to a mean value of 0.73 (range, 0.425 to 1.0). We
noted that although different clusters can be assigned to the iso-
lates 02K, 05K, 06K, 11K, 26K, 28K, 31K, and 33K, the patterns of
these clusters were closely related, and these clusters and unique
isolates may be considered a clonal complex (Fig. 3).
DISCUSSION
We performed an international multicenter evaluation of the
DiversiLab bacterial typing system for E. coli and Klebsiella spp. in
order to assess whether the DL system is suitable for comparing
isolates analyzed at different centers. Some local studies (8, 16–18)
showed that the DL system performed well for several species, e.g.,
Klebsiella spp., and to a lesser extent for some others, e.g., E. coli.
Moreover, it was shown to identify some of the circulating high-
risk clones such as E. coli ST131 harboring CTX-M-15 extended-
spectrum -lactamase and clonal complex 147 from K. pneu-
moniae expressing carbapenemases (19, 20).
In our study, 11 centers from six different countries typed 39 E.
coli and 39 Klebsiella species isolates that were selected based on
PFGE results. The main findings of the study were that (i) the DL
system had a lower discriminatory power for the E. coli isolates
than did PFGE, (ii) the clustering obtained by the different centers
was only partly concordant, and (iii) the central analysis improved
the clustering to an acceptable level. In comparison to PFGE typ-
ing, the DL system had less discriminatory power, creating larger
clusters and clustering of isolates that are considered unique by
using PFGE (Fig. 1 and 2). This has also been demonstrated by
other studies (21–23). The isolates considered to be different
by the DL system are also considered to be different by the PFGE.
A number of factors might have contributed to the less-than-
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FIG 1 (A) Comparison of the local clustering of E. coli and the clustering of the isolates using PFGE. The isolates belonging to one cluster according to the local
analysis or PFGE are indicated by the same color. (B) Comparison of the central clustering of E. coli and the clustering according to PFGE. The isolates belonging
to one cluster according to central analysis or PFGE are indicated by the same color. The isolates left blank were considered unique isolates according to the central
analysis. NT, nontypeable; NP, not processed by the center; NA, no amplification.
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optimal concordance between the centers. The main factors are
incorrect clustering by Pearson’s correlations and the misclassifi-
cation of isolates due to variations in the amplification products
between isolates. In some cases, the amplification signals were
faint or even completely absent, causing incorrect clustering by
Pearson’s correlations. In the central analysis, which relied com-
pletely on the interpretation of the overlays, more consistent clus-
tering was obtained (Fig. 1B and 2B). This was further aided by the
fact that, for each isolate, at least 10 replicates were available. This
allowed the assessment and mitigation of continuous minor
changes in the patterns of the isolates when the individual clusters
were examined. Sometimes the replicates for the same isolates did
not cluster next to each other but across the whole cluster (Fig. 3).
These data indicate that the reproducibility of one or more of the
steps before analysis is insufficient. Several issues that might be
responsible for this lack of reproducibility are (i) variations be-
tween the persons performing the assays, (ii) inconsistent ampli-
fication, and (iii) inconsistent quality and/or amounts of the DNA
obtained during its isolation. However, this also indicates the im-
portance of a central database for comparing isolates. Moreover,
person-to-person variations, variations in thermocycler perfor-
mance, and variations in the quality and amounts of the DNA
isolated are known from the experiences at the central laboratory
to lead to variations in the results (A. C. Fluit, unpublished data).
This study lacked an experimental design to measure person-to-
person variations within a center. Regardless, it is difficult to con-
trol for person-to-person variations, particularly within a multi-
center setting.
Inconsistent DNA amplification is most likely not due to the
PCR kits used, as these are quality checked for consistent perfor-
mance, and the same batches were used in all centers included in
this study. However, the thermocycler used may be a source of
variation, especially since during the amplification process in a
rep-PCR-based system, sometimes less-than-optimal interactions
between the primers and target occur, and slight differences in the
initial conditions, such as small variations in the primer concen-
trations, can have a major impact on the results. Although it is
possible at a local level to assign a single machine to the DL assays,
this is not feasible in a multicenter setting. One of the most im-
portant parameters in amplification is the quality and amount of
DNA added. The study protocol required a minimal amount and
quality of the DNA (25 ng/l and an OD260/OD280 ratio of 1.7
and an OD260/OD230 ratio of 1.3, respectively). These values,
however, still allow for variations between centers. In addition, the
possible use of different quantification platforms may contribute
to variations, as different platforms may yield different results
(A. C. Fluit, unpublished observations). Moreover, only 2 l of
the DNA solution is added, and small absolute variations lead to a
large relative variation in volume. Furthermore, amplification
products of different lengths are generated with one amplification
protocol, leading to competition for amplification. The variations
in DNA quality and amounts may be addressed by a more robust
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16K              
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FIG 2 (A) Comparison of the local clustering of Klebsiella spp. and the clustering of the isolates using PFGE. The isolates belonging to one cluster according to
the local analysis or PFGE are indicated by the same color. (B) Comparison of the central clustering of Klebsiella spp. and the clustering according to PFGE. The
isolates belonging to one cluster according to the central analysis or PFGE are indicated by the same color. The isolates left blank were considered unique isolates
according to the central analysis. NT, nontypeable; NV, nonviable.
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protocol. Automatic DNA extraction can be useful for better con-
trol of the DNA amounts and quality. It should be noted, though,
that the use of different types of automatic extraction machines
still might contribute to problems with the reproducibility of am-
plification.
The final factors that contributed to the differences in the as-
signment of the isolates to different clusters were errors in admin-
istration, exchange of isolates and/or results, and failure to adhere
to the protocol. These factors were most notable with the isolates
included for analysis that generated poor signals or warning sig-
nals, even if a good result from a retest was present.
Despite the ability of the amplification protocol and the DL
system to type every isolate in most centers, some centers reported
isolates that were nontypeable according to the given criteria.
Some centers retested isolates because the quality of the initial data
was unacceptable. All centers performed at least a small number of
retests, whereas a few of them required a considerable number of
retests, although the numbers of retests varied greatly; e.g., one
center retested 3 isolates once, and another center retested 90%
(70 of 78) of the isolates and retested 1 isolate seven times. This
also indicates that adequate training is required. No pattern with
particular isolates being retested more often than others was dis-
cerned among the centers.
We conclude that the DiversiLab system has the potential for
indicating the occurrence of outbreaks in an international setting,
at least for E. coli and Klebsiella spp., although with a lower dis-
criminatory power than that of PFGE. However, this will require
more reproducible DNA amplification and isolation methods,
strict adherence to protocols, and an international database to
allow the comparison of isolates. In addition, reference isolates
should be used with every chip to confirm the quality of each
amplification.
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